Aspire Health

Fund: 2013
Sector: Disruptive Technology

Aspire Health  is a healthcare company that specializes in providing an extra layer of support to patients facing a serious illness. Aspire’s clinicians are experts in providing patients with relief from the symptoms, pain, and stress of a serious illness; helping patients and caregivers navigate the healthcare system; guiding patients and caregivers through difficult and complex treatment choices and providing emotional and spiritual support to patients and their families.

visit website

Castle Biosciences

Fund: 2013, 2018
Sector: Life Sciences

Castle Biosciences is focused on developing and commercializing molecular diagnostics to aid health care professionals in assessing types and sub-types of tumors. Products focus on differentiating tumor types at the molecular level using various means of analyzing and comparing components of DNA.

visit website

Cerebrotech Medical Systems

Fund: 2013, 2018
Sector: Life Sciences

Cerebrotech Medical Systems has developed a non-invasive, continuous monitor for early detection of cerebral fluid change (primarily edema or bleeding) that can occur in a number of neurologic conditions, including stroke, traumatic brain injury, post brain surgery, etc.

visit website

Clearside Biomedical

Fund: 2013
Sector: Life Sciences

Clearside Biomedical is an ophthalmic company specializing in the research, development and commercialization of therapeutic products delivered through a proprietary microinjection platform that targets the suprachoroidal space in the region of the eye.

visit website

Contego Medical

Fund: 2013
Sector: Life Sciences

Contego Medical has developed a platform based on the integration of an embolic protection filter and a treatment device into a single catheter. By offering embolic protection on the same catheter as a balloon or stent, patients are offered a safer procedure without adding time, complexity, or expense and physicians can perform the procedure in less time.

visit website

Diabetes Care Group

Fund: 2013
Sector: Life Sciences

Diabetes Care Group is a healthcare services firm focused on treating diabetes through a proprietary, proven clinical delivery model that aids patients in controlling A1c levels. It’s a Fee-for-Results model that uses subscription-based and results-based bonuses, which allow patients to take advantage of services, such as nutritional counseling, that are typically not reimbursable under most healthcare plans. Since its founding in 2009, DCG has been organizing ideas around bringing diabetes medical management together with intensive, focused diabetes education in one location.

visit website

Diagnovus

Fund: 2013
Sector: Life Sciences

Diagnovus is focused on developing and commercializing molecular diagnostics to aid health care professionals in assessing types and sub-types of tumors. Products focus on differentiating tumor types at the molecular level using various means of analyzing and comparing components of DNA. The Company was acquired by Aegis Sciences Corporation in January 2015.

visit website

Evermind

Fund: 2013
Sector: Disruptive Technology

Evermind improves the lives of those who are living independently or managing a chronic disease, and those who provide care for them, by remotely monitoring the usage of home appliances and home medical equipment.

visit website

G1 Therapeutics

Fund: 2013
Sector: Life Sciences

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. The company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of first-in-class compounds and best-in-class drug candidates.

visit website

LineaGen

Fund: 2013
Sector: Life Sciences

LineaGen provides chromosomal microarray and next generation sequencing genetic testing for individuals with autism spectrum disorder and other post-natal developmental disorders.  Lineagen also provides both pre- and post-test genetic counseling to assess the impact of the results on the patient and other family members, as well as anticipatory guidance to physicians regarding potential clinical management changes.

visit website

MedCenterDisplay

Fund: 2013
Sector: Disruptive Technology

MedCenterDisplay is commercializing digital health networks in hospitals (and other provider settings) with screens in high wait-time and high traffic areas The Company was acquired by PatientPoint in November 2016.

visit website

Myomo

Fund: 2013
Sector: Life Sciences

Myomo is a medical device company that has developed a custom myoelectric elbow orthotic device, enabling individuals afflicted with stroke and other neuromuscular conditions to self-initiate and control movement of a partially paralyzed arm using their own muscle signals.

visit website

NeuroTronik

Fund: 2013
Sector: Life Sciences

NeuroTronik Limited is a medical device company focused on providing hemodynamic management of patients who are admitted with acute heart failure syndrome (“AHFS”). The NeuroTronik technology utilizes a patented intravascular electrode system capable of selectively stimulating parasympathetic and sympathetic nerves simultaneously or in a preferred cadence.

visit website

NuSirt

Fund: 2013
Sector: Life Sciences

NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as: obesity, diabetes, and inflammatory stress.

visit website

Odd Networks

Fund: 2013
Sector: Disruptive Technology

Odd Networks is a custom service provider for the distribution of content through interactive media. With decades of experience in the video game and digital media industry working to fundamentally changing the way content is consumed. Odd is composed of digital media experts, as well as creative designers and experienced developers.”

visit website

Orig3n

Fund: 2013
Sector: Disruptive Technology

ORIG3N is biotechnology company looking to develop breakthrough drug efficacy diagnostics for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications utilizing induced pluripotent stem cells.

visit website

Silicon Ranch

Fund: 2013, 2018
Sector: Disruptive Technology

Silicon Ranch Corporation is a developer and operator of utility scale solar facilities that provides turn-key renewable energy solutions to industry and utility partners.

visit website

SplitSecond

Fund: 2013
Sector: Disruptive Technology

Cyber Physical Systems, also known as SplitSecond, is a consumer product development and service company based in Nashville, TN. The Company develops telematics devices and associated applications that allow consumers and their loved ones to easily upgrade the safety of their vehicles, giving them peace of mind while driving; this is currently only enjoyed by a fraction of the driving public.

visit website